Reductions of carboxylic acid derivatives by silanes in the presence of rhodium complexes were studied. Carboxylic esters were reduced to alcohols by diphenylsilane catalyzed by [RhCl(cod)]2/4PPh3 or [RhCl(PPh3)3] at room temperature in up to 99% yields. For example, ethyl decanoate and ethyl phenylacetate were converted to decanol and 2-phenylethanol in 98 and 92% yields, respectively. Carboxylic acids were also reduced by this reducing system to the corresponding alcohols in high yields. Furthermore, N-monosubstituted amides were reduced to secondary amines in moderate to good yields. For sterically hindered amides, the yields were moderate, and imines were produced in competitive yields.
Ruthenium complexes, prepared by mixing the potassium salt of a-amino acids and [RuCl 2 (arene)] 2 , acted as catalysts for the asymmetric transfer hydrogenation of ketones from 2-propanol in the presence of KOH. For example, the transfer hydrogenation of acetophenone from 2-propanol was catalyzed effectively by the ruthenium complex prepared from potassium L-prolinate and [RuCl 2 (p-cymene)] 2 to give (R)-1-phenylethanol in 72% yield with 81% ee. The yields and enantioselectivities of the product were influenced strongly by the structure of the a-amino acidate ligand, arene ligand, and substrate, by the amount of additional base, and by the concentration of the substrates. The best enantiomeric excesses of the products was 92%, when 1-tetralone was subjected to this reaction using a prolinated ruthenium complex bearing p-cymene. Furthermore, the potassium salts of dipeptides were tested as a ligand for this transfer hydrogenation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.